Skip to main content

Mikrozirkulationsstörung, zytopathische Hypoxie und septische Kardiomyopathie

  • Chapter
  • First Online:
Sepsis und MODS

Zusammenfassung

Der septische Schock ist mehr als nur ein Kreislaufschock der großen Gefäße! Die Mikrozirkulationsstörung mit Stase senkt die Prognose und ist derzeit keiner gezielten Therapie zugängig. Die therapierefraktäre „zytopathische Hypoxie“ trägt wesentlich zur Energieverarmung der Gewebe bei. Die potenziell reversible septische Kardiomyopathie wird wesentlich durch die diastolische Dysfunktion geprägt. Sie ist am besten mit dem nachlastbezogenen kardialen Herzzeitvolumen („afterload-related cardiac performance“, ACP) zu quantifizieren; die Schwere korreliert mit der Letalität. Die kardiale autonome Dysfunktion manifestiert sich als Herzfrequenzstarre und inadäquat hohe Herzfrequenz, teils erklärt durch die Endotoxin/Schrittmacherkanal(I f)-Interaktion. Die Therapie folgt der Standardtherapie des septischen Schocks, in Erprobung sind der Kalziumsensitizer Levosimendan, der kurzwirksame β-Blocker Esmolol (Senkung der inadäquat hohen Herzfrequenz) und der Schrittmacherkanalinhibitor Ivabradin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D (2011) Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med 37 (8): 1344–1351

    Article  CAS  PubMed  Google Scholar 

  • Amman P, Fehr T, Minder EI et al. (2001) Elevation of troponin I in sepsis and septic shock. Intensive Care Med 27: 965–969

    Article  Google Scholar 

  • Annane D, Sébille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Bellissant E (2008) Incidence and Prognosis of Sustained Arrhythmias in Critically Ill Patients. Am J Resp Crit Care Med 178: 20–24

    Article  PubMed  Google Scholar 

  • Antonucci E, Fiaccador E, Donadello K, Taccone FS, Franchi F, Scolletta S (2014) Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment. Journal of Critical Care 29: 500–511 [Sehr gute aktuelle Übersichtsarbeit mit Schwerpunkt Pathophysiologie.] ←

    Google Scholar 

  • Awan ZA, Wester T, Kvernebo K (2010) Human microvascular imaging: a review of skin and tongue videomicroscopy techniques and analysing variables. Clin Physiol Funct Imaging 30: 79–88

    Article  CAS  PubMed  Google Scholar 

  • Basu S, Frank LH, Fenton KE, Sable CA, Levy RJ, Berger JT (2012) Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography. Pediatr Crit Care Med 13: 259–264

    Article  PubMed  Google Scholar 

  • Beraud AS, Guillamet CV, Hammes JL, Meng L, Nicolls MR, Hsu JL (2014) Efficacy of Transthoracic Echocardiography for Diagnosing Heart Failure in Septic Shock. Am J Med Sciences 347 (4): 295–298

    Article  Google Scholar 

  • Berrios RAS, O’Horo JC, Velagapudi V, Pulido JN (2014) Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: A systematic review and meta-analysis. J Crit Care 29: 495–499

    Article  Google Scholar 

  • Bessiere F, Khenifer S, Dubourg J, Durieu I, Lega JC (2013) Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med 39: 1181–1189

    Article  CAS  PubMed  Google Scholar 

  • Boekstegers P, Weidenhöfer S, Kapsner S, Werdan K (1994) Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 22 (4): 640–650

    Article  CAS  PubMed  Google Scholar 

  • Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Féger F, Rouby JJ (2009) Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 37: 441–447

    Article  PubMed  Google Scholar 

  • Briassoulis G, Narliloglou M, Zavras N, Hatzis T (2001) Myocardial injury in meningococcus-induced purpura fulminans in children. Intensive Care Med 27: 1073–1082

    Article  CAS  PubMed  Google Scholar 

  • Carre JE, Orban JC, Re L, Felsmann K, Iffert W, Bauer B, Suliman HB, Piantadosi CA, Mayhew TM, Breen P, Stotz M, Singer M (2010) Survival in Critical Illness Is Associated with Early Activation of Mitochondrial Biogenesis. Am J Resp Crit Care Med 382: 745–751

    Article  Google Scholar 

  • Celes MRN, Prado CM, Rossi MA (2013) Sepsis: Going to the Heart of the Matter. Pathobiology 80: 70–86

    Article  PubMed  Google Scholar 

  • Cotter G, Moshkovitz Y, Kaluski E et al. (2003) The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Failure 5: 443–451

    Article  Google Scholar 

  • Crouser ED (2004) Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4 (5–6): 729–741

    Article  CAS  PubMed  Google Scholar 

  • De Backer D, Creteur J, Dubois MJ, Sakr Y, Koch M, Verdant C, Vincent JL (2006) The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 34 (2): 403–408

    Article  CAS  PubMed  Google Scholar 

  • De Backer D, , Creteur J, , Preiser JC, et al (2002) Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care 166: 98–104 [Sorgfältige klinische Studie, welche erstmals systematisch die sepsisbedingten Störungen der Mikrozirkulation beschreibt und quantifiziert.] ←

    Google Scholar 

  • Dellinger PR, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; the Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup (2013) Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 41 (2): 580–637 und Intensive Care Med 39 (2): 165–228 (siehe auch Servicteil S. 376).

    Google Scholar 

  • Dhainaut JF, Pinsky MR, Nouria S, Slomka F, Brunet F (1997) Right ventricular function in human sepsis – a thermodilution study. Chest 112: 1043–1049

    Article  CAS  PubMed  Google Scholar 

  • Ebelt H, Geißler I, Ruccius S, Otto V, Hoffmann S, Korth H, Klöckner U, Zhang Y, Li Y, Grossmann C, Rueckschloss U, Gekle M, Stieber J, Frantz S, Werdan K, Müller-Werdan U, Loppnow H (2015) Direct inhibition, but indirect sensitization of pacemkaer activity to sympathetic tone by the interaction of endotoxin with HCN channels. Clin Exp Pharmacol Physiol 42(8):874–880

    Google Scholar 

  • Edul VSK, Enrico C, Laviolle B, Vazquez AR, Ince C, Dubin A (2012) Quantitative assessment of the microcirulation in healthy volunteers and in patients with septic shock. Crit Care Med 40: 1443–1448

    Article  PubMed  Google Scholar 

  • Fernandez Jr CJ de Assuncao MSC (2012) Mycoardial Dysfunction in Sepsis: A Large, Unsoved Puzzle. Critical Care Research and Practice 2012: 896430 [Der Fokus liegt auf aktuellen Forschungsschwerpunkten.] ←

    Google Scholar 

  • Gach O, Lancellotti P, Pierard LA (2001) Acute ST-segment elevation in Neisseria meningitidis. Acta Cardiol 56: 327–329

    Article  CAS  PubMed  Google Scholar 

  • Gellerich FN, Trumbeckaite S, Opalka JR, Gellerich JF, Chen Y, Neuhof C, Redl H, Werdan K, Zierz S (2002) Mitochondrial dysfunction in sepsis: evidence from bacteraemic baboons and endotoxaemic rabbits. Bioscience Rep 22 (1): 99–113

    Article  CAS  Google Scholar 

  • Hernandez G, Bruhn A, Luengo C, Regueira T, Kattan E, Fuentealba A, Florez J, Castro R, Aquevedo A, Pairumani R, McNab P, Ince C (2013) Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. Intensive Care Med 39 (8): 1435–1443

    Article  CAS  PubMed  Google Scholar 

  • Hoffmann B, Welte T (2002) Der akute Myokardinfarkt – ein unterschätzter und oft unerkannter Mortalitätsfaktor bei septischen Patienten? Intensivmed 39: 677–681

    Article  Google Scholar 

  • Hoke RS, Müller-Werdan U, Lautenschläger C, Werdan K, Ebelt H (2012) Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective observational study. Clin Res Cardiol 101 (2): 139–147

    Article  PubMed  Google Scholar 

  • Klöckner U, Rueckschloss U, Grossmann C, Matzat S, Schumann K, Ebelt H, Müller-Werdan U, Loppnow H, Werdan K, Gekle M (2014) Inhibition of cardiac pacemaker channel hHCN2 depends on intercalation of lipopolysaccharide into channel-containing membrane microdomains. J Physiol 592.6: 1199–1211

    Article  Google Scholar 

  • Krishnagopalan S, Kumar A, Parrillo JE, Kumar A (2002) Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 8: 376–388

    Article  PubMed  Google Scholar 

  • Kuipers S, Klein Klouwenberg PMC, Cremer OL (2014) Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Critical Care 18: 688

    Article  PubMed Central  PubMed  Google Scholar 

  • Kumar A, Haery C, Parrillo JE (2001a) Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 15 (3): 364–376 [Ausgezeichnete Übersicht über die Herz-Kreislauf-Veränderungen in der Sepsis, wesentlich erforscht von der Parrillo-Gruppe!] ←

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Krieger A, Symeoneides S, Kuar A, Parrillo JE (2001b) Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitrix oxide. J Cardiothorac Vasc Anesth 15 (4): 485–511 [Überzeugende Darstellung der Bedeutung dieser Substanzen bei der septischen Myokarddysfunktion, wesentlich erforscht von der Parrillo-Gruppe!] ←

    Article  CAS  PubMed  Google Scholar 

  • Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, Avidan A, Beeri R, Weissman C, Jaffe AS, Sprung CL (2012) Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 33: 895–903 [Ausgezeichnete monozentrische Kohortenstudie an 262 Patienten, welche mittels Gewebedoppler-Echokardiographie Häufigkeit und prognostische Relevanz der systolischen und diastolischen Dysfunktion bei schwerer Sepsis und septischem Schock beschreibt!] ←

    Google Scholar 

  • Landesberg G, Jaffe AS, Gillon D, Levin PD, Goodman S, Abu-Baih A, Beeri R, Weissman C, Sprung CL, Landesberg A (2014) Troponin Elevation in Severe Sepsis and Septic Shock: The Role of Left Ventricular Diastolic Dysfunction and Right Ventricular Dilatation. Crit Care Med 42: 790–800

    Article  CAS  PubMed  Google Scholar 

  • Levy RJ (2007) Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock 28 (1): 24–28

    Article  CAS  PubMed  Google Scholar 

  • Levy RJ, Piel DA, Acton PD, et al (2005) Evidence of myocardial hibernation in the septic heart. Crit Care Med 33: 2752–2756

    Article  PubMed  Google Scholar 

  • Lim W, Whitlock R, Khera V, Devereux PJ, Tkaczyk A, Heels-Ansdell D, Jack M, Cook D (2010) Etiology of troponin elevation in critically ill patients. J Crit Care 25: 322–328

    Article  PubMed  Google Scholar 

  • Mehta S, Granton J, Lapinsky SE, Newton G, Bandayrel K, Little A, Siau C, Cook DJ, Ayers D, Singer J, Lee TC, Walley KR, Storms M, Cooper J, Holmes CL, Hebert P, Gordon AC, Presneill J, Russell JA, the Vasopressin and Septic Shock Trial (VASST) Investigators (2011) Agreement in electrocardiogram interpretation in patients with septic shock. Crit Care Med 39 (9): 2080–2086. Editorial: van Haren, 2187–2189 [Systematische Analyse von EKG-Veränderungen bei Patienten mit septischem Schock, zeigt die Schwierigkeiten der Interpretation!] ←

    Article  PubMed  Google Scholar 

  • Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, Bögelein D, Gauss A, Georgieff M, Stahl W (2010) Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care 14: R108

    Article  PubMed Central  PubMed  Google Scholar 

  • Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31 (5): 638–644

    Article  PubMed  Google Scholar 

  • Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, De Gaetano A, Picchini U, Orecchioni A, Carbone I, Tritapepe L, Pietropaoli P, Westphal M (2006) Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 34 (9): 2287–2293

    Article  CAS  PubMed  Google Scholar 

  • Morelli A, Donati A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Landoni G, Pelaia P, Pietropaoli P, Van Aken H, Teboul JL, Ince C, Westphal M (2010) Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study. Crit Care 14 (6): R232

    Article  PubMed Central  PubMed  Google Scholar 

  • Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D’Egidio A, D’Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M, (2013) Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock - A Randomized Clinical Trial. JAMA 310 (16): 1683–1691

    Article  PubMed  Google Scholar 

  • Morelli A, Passariello M, Singer M (2014) Inotropic Support in the Treatment of Septic Myocardial Dysfunction: Pathophysiological Implications Supporting the Use of Levosimendan. In: Vincent JL (ed.) Annual Update in Intensive Care and Emergency Medicine 2014. Springer International Publishing: Switzerland, S. 407–419

    Google Scholar 

  • Müller-Werdan U, Reithmann C, Werdan K (1996) Cytokines and the heart: molecular mechanisms of septic cardiomyopathy. Medical Intelligence Unit. Springer: Heidelberg, Germany/RG Landes Company Austin, USA

    Google Scholar 

  • Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K (2011) Reducing elevated heart rate in patients with multi organ dysfunction syndrome by the I f (funny channel current) inhibitor ivabradine. Clin Res Cardiol 100 (10): 915–923

    Article  CAS  PubMed  Google Scholar 

  • Ouelette DR, Shah SZ (2014) Comparison of outcomes from sepsis between patients with and without pre-existing left ventricular dysfunction: a case-control analysis. Critical Care 18: R79

    Article  Google Scholar 

  • Parrillo JE (1989) The cardiovascular pathophysiology of sepsis. Ann Rev Med 40: 469–485 [Ausgezeichnete zusammenfassende Erstbeschreibung der Herzschädigung in der Sepsis. Der Autor und sein Team waren maßgeblich an der Erforschung der Herzschädigung in der Sepsis beteiligt.] ←

    Google Scholar 

  • Pierrakos C, Velissaris D, Franchi F, Muzzi L, Karanikolas M, Scoletta S (2014) Levosimendan in Critical Illness: A Literature Review. J Clin Med Res 6 (2): 75–85

    PubMed Central  CAS  PubMed  Google Scholar 

  • Pranskunas A, Koopmans M, Koetsier PM, Pilvinis V, Boerma EC (2013) Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med 39: 612–619

    Article  Google Scholar 

  • Romberg E (1921) Die septische akute Myokarditis. In: Romberg H (Hrsg) Lehrbuch der Krankheiten des Herzens und der Blutgefäße (3. Aufl.) Enke: Stuttgart, S. 494

    Google Scholar 

  • Romero-Bermejo FJ, Ruiz-Bailen M, Gil-Cebrian J, Huertos-Ranchal MJ (2011) Sepsis-induced Cardiomyopathy. Current Cardiology Reviews 7: 163–183 [Eine exzellente, umfassende Übersichtsarbeit: beschreibt alle wichtigen Aspekte der Pathophysiologie und Klinik!] ←

    Google Scholar 

  • Rossi MA, Celes MRN, Prado CM, Saggioro FP (2007) Myocardial structural changes in long-term severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock 27 (1): 10–18 [Eine der wenigen histopathologischen Untersuchungen der Herzveränderungen bei an Sepsis verstorbenen Patienten!] ←

    Article  CAS  PubMed  Google Scholar 

  • Salman S, Bajwa A, Gajic O, Afessa B (2008) Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med 23 (3): 178–183

    Article  PubMed  Google Scholar 

  • Saugel B, Trepte CJ, Reuter DA (2014) Macro- and Microcirculation in Systemic Inflammation: An Approach to Close the Circle. In: Vincent JL (ed.) Annual Update in Intensive Care and Emergency Medicine 2014. Springer International Publishing: Switzerland, S. 325–339

    Google Scholar 

  • Scheruebel S, Koyani CN, Hallström S, Lang P, Platzer D, Mächler H, Lohner K, Malle E, Zorn-Pauly K, Pelzmann B (2014) I f blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes. J Mol Cell Cardiol 72: 64–73

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Schmidt H, Flieger RR, Hennen R, Tymiec P, Winkler M, Hoyer D, Buerke M, Müller-Werdan U, Werdan K (2005) Reversible autonome Dysfunktion bei einer jungen Patientin mit septischem Multiorgandysfunktionssyndrom. Dtsch Med Wochenschr 130: 648–651

    Article  CAS  PubMed  Google Scholar 

  • Schmidt H, Hoyer D, Rauchhaus M, Prondzinsky R, Hennen R, Schlitt A, Carter J, Hottenrott K, Müller-Werdan U, Werdan K, Buerke M (2010) ACE-inhibitor therapy and survival among patients with multiorgan dysfunction syndrome (MODS) of cardiac and non-cardiac origin. Int J Cardiol 140: 296–303

    Article  PubMed  Google Scholar 

  • Schmittinger CA, Dünser MW, Torgersen C, Luckner G, Lorenz I, Schmid S, Joannidis M, Moser P, Hasibeder WR, Halabi M, Steger CM (2013) Histologic pathologies of the myocardium in septic shock: a prospective, observational study. Shock 39: 329–441

    Article  CAS  PubMed  Google Scholar 

  • Sturgess DJ, Marwick TH, Joyce C, Jenkins C, Jones M, Masci P, Stewart D, Venkatesh B (2010) Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Critical Care 14: R44

    Article  PubMed Central  PubMed  Google Scholar 

  • Tracey KJ (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117: 289–296 [Exzellente Darstellung des Zusammenhangs von autonomem Nervensystem und Inflammation durch den Erstbeschreiber des cholinergen antiinflammatorischen Reflexes!] ←

    Google Scholar 

  • Trzeciak S, McCoy JV, Phillip Dellinger R, Arnold RC, Rizzuto M, Abate NL, Shapiro NI, Parrillo JE, Hollenberg SM; Microcirculatory Alterations in Resuscitation and Shock (MARS) investigators (2008) Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 34: 2210–2217

    Article  PubMed Central  PubMed  Google Scholar 

  • Tsapenko MV, Herasevich V, Mour GK, Tsapenko AV, Comfere TBO, Mankad SV, Cartin-Ceba R, Gajic O, Albright RC (2013) Severe sepsis and septic shock in patients with pre-existing non-cardiac pulmonary hypertension: contemporary management and outcomes. Crit Care Resusc 15: 103–119

    PubMed  Google Scholar 

  • V.E. Papaioannou (Editor) Frontiers in Myocardia (Vol 1) „Septic Cardiomyopathy from Bench-to-bedside“ (Edited by Bentham Sience Publishers Ltd., Sharjahm U.A.E. 2015

    Google Scholar 

  • Vignon P (2013) Ventricular diastolic abnormalities in the critically ill. Curr Opin Crit Care 19: 242–249

    Article  PubMed  Google Scholar 

  • Walkey AJ, Wiener RS, Ghobrial J, Curtis LH, Benjamin EJ (2011) Incident Stroke and Mortality Associated With New-Onset Atrial Fibrillation in Patients Hospitalized With Severe Sepsis. JAMA 306 (20): 2248–2255. Editorial Comment: Goss CH, Carson SS: 2264-2266 [Diese retrospektive populationsbezogene Korhortenstudie hat bei 49.082 Sepsispatienten ein 7-fach häufigeres Auftreten von Vorhofflimmern und ein 3-fach höheres daraus resultierendes Schlaganfallrisiko gefunden.] ←

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Werdan K, Hettwer S, Bubel S, Oelke A, Hoke RS, Wimmer R, Ebelt H, Müller-Werdan U (2009a) Septischer Kreislaufschock und septische Kardiomyopathie. Internist 50: 799–809

    Article  CAS  PubMed  Google Scholar 

  • Werdan K, Nuding S, Müller-Werdan U (2015) Potential Pathophysiological Mechanisms in Septic Cardiomyopathy: an Overview. In: Frontiers in Myocardia (Vol 1) "Septic Cardiomyopathy from Bench-to-bedside" (Edited by V.E. Papaioannou. Bentham Sience Publishers Ltd., Sharjahm U.A.E. 2015, pp 3–40

    Chapter  Google Scholar 

  • Werdan K, Oelke A, Hettwer S, Nuding S, Bubel S, Hoke R, Ruß M, Lautenschläger C, Mueller-Werdan U, Ebelt H (2011) Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications. Clin Res Cardiol 100 (8): 661–668

    Article  PubMed  Google Scholar 

  • Werdan K, Schmidt H, Ebelt H, Zorn-Pauly K, Koidl B, Hoke RS, Heinroth K, Müller-Werdan U (2009b) Impaired regulation of cardiac function in sepsis, SIRS and MODS. Can J Physiol Pharmacol 87: 266–274

    Article  CAS  PubMed  Google Scholar 

  • Wilhelm J, Hettwer S, Schuermann M, Bagger S, Gerhardt F, Mundt S, Muschik S, Zimmermann J, Amoury M, Ebelt H, Werdan K. (2014) Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implications. Clin Res Cardiol 103 (7): 561–567

    Article  CAS  PubMed  Google Scholar 

  • Wilhelm J, Hettwer S, Schuermann M, Bagger S, Gerhardt S, Mundt S, Muschik S, Zimmermann J, Bubel S, Amoury M, Klöss T, Finke R, Loppnow H, Mueller-Werdan U, Ebelt H, Werdan K (2013) Severity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis. Clin Res Cardiol 102 (10): 735–744

    Article  CAS  PubMed  Google Scholar 

  • Wu AHB (2001) Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 27: 959–961

    Article  CAS  PubMed  Google Scholar 

  • Zaky A, Deem S, Bendjelid K, Treggiari MM (2014) Characterization of cardiac dysfunction in sepsis: an ongoing challenge. Shock 2014; 41 (1): 12–24 [Sehr gute aktuelle Übersichtsarbeit mit Schwerpunkt „klinische Aspekte“.] ←

    Google Scholar 

  • Zang QS, Wolf SE, Minei JP (2014) Sepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the Elderly. Aging Disease 5 (2): 137–149

    PubMed Central  PubMed  Google Scholar 

  • Zanotti CSL, Gugliehnim, Parrillo JE, Walker T, Dellinger P, Hollenberg SM (2010) Ventricular Dilation Is Associated With Improved Cardiovascular Performance and Survival in Sepsis. Chest 138 (4): 848–855

    Google Scholar 

  • Zorn-Pauly K, Pelzmann B, Lang P, Mächler H, Schmidt H, Ebelt H, Werdan K, Koidl B, Müller-Werdan U (2007) Endotoxin impairs the human pacemaker current I f. Shock 28 (6): 655–661

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. Müller-Werdan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Müller-Werdan, U., Ebelt, H., Wilhelm, J., Wimmer, R., Buerke, M., Werdan, K. (2016). Mikrozirkulationsstörung, zytopathische Hypoxie und septische Kardiomyopathie. In: Werdan, K., Müller-Werdan, U., Schuster, HP., Brunkhorst, F. (eds) Sepsis und MODS. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45148-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45148-9_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45147-2

  • Online ISBN: 978-3-662-45148-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics